The long-term effect of marine n-3 polyunsaturated fatty acid supplementation on glomerular filtration rate and development of fibrosis in the renal allograft: a randomized double blind placebo controlled intervention study - EMiRA

Akershus University Hospital0 个研究点目标入组 174 人开始时间: 2017年11月9日最近更新: 2017年11月13日

试验速览

暂无简介。

•- Renal transplant recipients over 18 years of age.
•- Stable renal graft function, defined as eGFR >30 ml/min at the last 2 visits.
•- 6–60 months post-transplantation at randomization.
•- Signed informed consent.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 100
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 74

•- Patients who participate in a clinical trial with other investigational drugs.
•- Patients with a history of an allergic reaction or significant sensitivity to fish, seafood and the study drug Omacor or drugs or dietary supplements similar to the study drug.
•- Any reason why, in the opinion of the Principal Investigator, the patient should not participate - E.g. history of repeated non-adherence to prescribed treatment, repeated non-attendance to clinic visits, cognitive impairment that prevents understanding the nature of this study, etc.

发起方

Akershus University Hospital